Nearly a decade after the collapse of Theranos, the company continues to cast a long shadow over the global Deep Tech investment landscape. Once celebrated as a revolutionary healthcare innovator promising cancer detection from only a few drops of blood, Theranos ultimately became one of the most notorious corporate frauds in modern technology history.